Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Eurofins Technologies Gets CE-IVD Mark for Multiplex Coronavirus Test

Eurofins Technologies Gets CE-IVD Mark for Multiplex Coronavirus Test

May 07, 2020
|
staff reporter

NEW YORK — Eurofins Technologies said on Thursday that it has received CE-IVD marking for the GSD NovaPrime SARS-CoV-2 (COVID-19) test.

The multiplex RT-PCR test simultaneously detects two target sequences inside the SARS-CoV-2 N gene, providing results in about two hours, according to the company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Molecular Diagnostics

  1. Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings

  2. Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

  3. Reference Labs Take Diverse Approaches to Mitigating COVID-19 Sample Shipping Delays

    Premium

  4. William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating

  5. FDA Grants Emergency Use Authorization for University of Illinois Coronavirus PCR Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.